With NCI Director Sharpless in as interim FDA head, what does that mean for interagency cooperation?

Published: 12/03/2019
With NCI Director Sharpless in as interim FDA head, what does that mean for interagency cooperation?
Source: WWW.FIERCEBIOTECH.COM

The announcement that NCI Director Ned Sharpless will take on the role of acting commissioner of the FDA has raised some intriguing speculation about the possibilities for interagency cooperation between the federal government’s main medical research and innovation arm and its industry regulator.

Read more
Related news
Comment
Latest in blog
FACEBOOK